aDepartment of Medicinal Chemistry, Ranbaxy Research Laboratories, Gurgaon 122001, India;bDepartment of Pharmacology, Ranbaxy Research Laboratories, Gurgaon 122001, India
Abstract:
The induction of conformationally restricted N-(aryl or heteroaryl)-3-azabicyclo[3.1.0]hexane derivatives at P2 region of compounds of 2-cyanopyrrolidine class was explored to develop novel DPP-IV inhibitors. The synthesis, structure–activity relationship, and selectivity against related proteases are delineated.